Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05229718 · ClinicalTrials.gov registry record · NA
Understanding and Optimizing Care for Young Adults With Type 1 and Type 2 Diabetes Mellitus Transitioning to Adult Care
A NA study of Type 2 Diabetes and Type 1 Diabetes, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT05229718: Active NA study of Type 2 Diabetes and Type 1 Diabetes, sponsored by Massachusetts General Hospital.
NCT05229718 is a NA study of Type 2 Diabetes and Type 1 Diabetes that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 45 participants, below the 3,924-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05229718, a NA study of Type 2 Diabetes and Type 1 Diabetes, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, we will determine the feasibility of an innovative care model for young adults with diabetes and compare the primary and secondary outcomes in the innovative model to those in the usual care model for adult diabetes management at Massachusetts General Hospital (MGH) Diabetes Center.
Primary Outcome
Mean number of completed visits compared to scheduled visits (visit completion rate) in patients seen in the collaborative care and usual care models
Conditions Studied
Interventions
- OTHER Diabetes Collaborative Care Model for Young Adults
- OTHER Usual Care Model
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2021-10-01 |
| Est. Completion | 2025-11-30 |
| Phase | NA |
What the registry record for NCT05229718 still lists
NCT05229718 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 3,924-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Diabetes Collaborative Care Model for Young Adults is the first listed.
NCT05229718 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05229718 about?
NCT05229718 is a clinical study titled "Understanding and Optimizing Care for Young Adults With Type 1 and Type 2 Diabetes Mellitus Transitioning to Adult Care". In this study, we will determine the feasibility of an innovative care model for young adults with diabetes and compare the primary and secondary outcomes in the innovative model to those in the usual care model for adult diabetes management at Massachusetts General Hospital (MGH) Diabetes Center.
What is the current status of trial NCT05229718?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2021-10-01. Estimated completion is 2025-11-30.
What conditions does trial NCT05229718 study?
This clinical trial studies the following conditions: Type 2 Diabetes, Type 1 Diabetes.
What interventions are being tested in trial NCT05229718?
The interventions under investigation include: Diabetes Collaborative Care Model for Young Adults (OTHER), Usual Care Model (OTHER).
Who is sponsoring clinical trial NCT05229718?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05229718 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05229718's enrollment target sits among peer trials
45 219th of 327 higher than 108 of 327 other Type 2 Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
RECRUITING · NA
-
High Fructose Diet, the Gut Microbiome, and Metabolic Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI